Anna Esteve
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Parvovirus B19 Infection Studies
Papers in
- Oncology 16
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer Immunotherapy and Biomarkers 4
-
- HIV/AIDS Research and Interventions 11
- HIV/AIDS drug development and treatment 6
- Co-authors
- Jordi Casabona (11 shared papers)Denise Whitby (3 shared papers)Gemma Gambús (2 shared papers)Cinta Folch (4 shared papers)Cristina Tural (6 shared papers)Thomas F. Schulz (2 shared papers)Bonaventura Clotet (5 shared papers)Elisa Martró (2 shared papers)
- Journals
- Clinical & Translational Oncology (3 papers)Annals of Oncology (3 papers)Cancers (2 papers)Frontiers in Oncology (2 papers)AIDS (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Anna Esteve
34 papers receiving 382 citations
Peers
Comparison fields: 5 of 57
- Virology 96
- Infectious Diseases 235
- Epidemiology 211
- Oncology 135
- Emergency Medicine 33
Countries citing papers authored by Anna Esteve
This map shows the geographic impact of Anna Esteve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Esteve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Esteve more than expected).
Fields of papers citing papers by Anna Esteve
This network shows the impact of papers produced by Anna Esteve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Esteve. The network helps show where Anna Esteve may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Esteve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 52 | |
| 2 | 2001 | 50 | |
| 3 | 2008 | 44 | |
| 4 | 2005 | 33 | |
| 5 | 2007 | 26 | |
| 6 | 2004 | 24 | |
| 7 | 2017 | 20 | |
| 8 | 2015 | 20 | |
| 9 | 2014 | 19 | |
| 10 | 2008 | 18 | |
| 11 | 2018 | 16 | |
| 12 | 2012 | 13 | |
| 13 | 2015 | 12 | |
| 14 | 2018 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2008 | 4 | |
| 17 | 2006 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2025 | 2 |
About Anna Esteve
Anna Esteve is a scholar working on Oncology, Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine and Sociology and Political Science, having authored 37 papers that have together received 392 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (11 papers), Sex work and related issues (6 papers), HIV, Drug Use, Sexual Risk (6 papers), HIV/AIDS drug development and treatment (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), HIV Research and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Virology (96 citations), Infectious Diseases (235 citations), Epidemiology (211 citations), Oncology (135 citations) and Emergency Medicine (33 citations). Anna Esteve has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Jordi Casabona, Denise Whitby, Gemma Gambús, Cinta Folch, Cristina Tural, Thomas F. Schulz, Bonaventura Clotet, Elisa Martró, Lluís Force and Felipe García. Their work appears in journals such as Clinical & Translational Oncology, Annals of Oncology, Cancers, Frontiers in Oncology and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.